- Market Realist•yesterday
The Fidelity Advisor Europe Fund Class A has fallen 5% year-to-date, but it's still an average performer in the group of 12 funds chosen for this review.
- Capital Cube•28 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Novozymes A/SHere are 5 ETF’s with the largest exposure to NVZMY-US. Comparing the performance and risk of Novozymes A/S with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to Novozymes A/S : June 30, 2016 appeared first on CapitalCube.
|52wk Range||37.98 - 53.21|
|Day's Range||48.84 - 49.12|
|Avg Vol (3m)||14,809|
As of 3:30 PM EDT. Other OTC Delayed Price. Market open.